Table 4 Correlation between clinical stage and tumor biomarkers.
STAGE II (%) | STAGE III/IV (%) | X 2 | P Value | |
|---|---|---|---|---|
Telomerase activity | ||||
Positive | 7 (50.0) | 19 (63.3) | 0.7 | 0.4 |
Negative | 7 (50.0) | 11 (36.7) | ||
Bcl-2 | ||||
Positive | 14(100) | 21 (70) | 5.28 | 0.02* |
Negative | 0 (0) | 9 (30) | ||
Estrogen Receptor α | ||||
Positive | 13(92.9) | 26 (86.7) | 0.36 | 0.55 |
Negative | 1 (7.1) | 4 (13.3) | ||
Estrogen Receptor β | ||||
Positive | 4 (28.6) | 12 (40) | 0.54 | 0.46 |
Negative | 10(71.4) | 18 (60) |